2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K.·1995·Biochemical and Biophysical Research Communications
DOI 10.1006/bbrc.1995.2437

Cited by (1,009)

Items 701–800 of 1,009

  1. Generation of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, in Picrotoxinin-Administered Rat Brain
    Takayuki Sugiura, Naoki Yoshinaga, Sachiko Kondo, Keizo Waku, Yoshio Ishima · 2000 · Biochemical and Biophysical Research Communications
  2. The endocannabinoid system
    Aruna Kilaru, Kent Dean Chapman · 2020 · Essays in Biochemistry
  3. Phytocannabinoid Pharmacology: Medicinal Properties of Cannabis sativa Constituents Aside from the “Big Two”
    Peter B. Sampson · 2020 · Journal of Natural Products
  4. Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
    Ahmed Hasbi, Bertha Kalifon Madras, Susan R. George · 2023 · Brain Sciences
  5. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands
    Tamaki Hayase, Yoshio Yamamoto, Keiichi Yamamoto · 2005 · Behavioural Pharmacology
  6. The invertebrate ancestry of endocannabinoid signalling: an orthologue of vertebrate cannabinoid receptors in the urochordate Ciona intestinalis
    Maurice R. Elphick, Yutaka Satou, Nori Satoh · 2003 · Gene
  7. ROLE OF THE ENDOCANNABINOID SYSTEM IN THE DEVELOPMENT OF TOLERANCE TO ALCOHOL
    Balapal S. Basavarajappa, Basalingappa L. Hungund · 2004 · Alcohol and Alcoholism
  8. Monoglyceride lipase: Structure and inhibitors
    Laura Scalvini, Daniele Piomelli, Marco Mor · 2015 · Chemistry and Physics of Lipids
  9. NewN-Arachidonoylserotonin Analogues with Potential “Dual” Mechanism of Action against Pain
    Giorgio Ortar, Maria Grazia Cascio, Luciano De PETROCELLIS, Enrico Morera, Francesca Rossi, Aniello Schiano Moriello, Marianna Nalli, Vito de Novellis, David F. Woodward, Sabatino Maione et al. · 2007 · Journal of Medicinal Chemistry
  10. Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats
    Antonia Manduca, Maria Morena, Patrizia Campolongo, Michela Servadio, Maura Palmery, Luigia Trabace, Matthew N. Hill, Louk J. M. J. Vanderschuren, V. Cuomo, Viviana Trezza · 2015 · European Neuropsychopharmacology
  11. Cannabinoid–hormone interactions in the regulation of motivational processes
    Hassan H. López · 2009 · Hormones and Behavior
  12. Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
    África Flores, Rafael J. Maldonado, Fernando Berrendero · 2013 · Frontiers in Neuroscience
  13. Nutritional Properties of Dietary Omega-3-Enriched Phospholipids
    Elisabetta Murru, Sebastiano Banni, Gianfranca Carta · 2013 · BioMed Research International
  14. Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival
    Esther Martínez-Martínez, Irene Gómez, Paloma Martín, Antonio Sánchez, Laura Román, Eva E. Tejerina, Félix Bonilla, Antonio García Merino, Antonio Garcı́a de Herreros, Mariano Provencio et al. · 2015 · Oncoscience
  15. Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder
    Luke John Ney, Allison Jane Matthews, Raimondo Bruno, Kim Louise Felmingham · 2018 · Neuroscience & Biobehavioral Reviews
  16. Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs
    Nunzio Sepe, Luciano De PETROCELLIS, Francesca Montanaro, Guido Cimino, Vincenzo Di Marzo · 1998 · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
  17. Evidence for an endocannabinoid system in the central nervous system of the leech Hirudo medicinalis
    Isabel Matias, Tiziana Bisogno, Dominique J. Melck, Franck Vandenbulcke, Martine Verger‐Bocquet, Luciano De PETROCELLIS, Christian Sergheraert, Christophe Breton, Vincenzo Di Marzo, Michel Salzet · 2001 · Molecular Brain Research
  18. Blockade of cannabinoid CB1 receptors alters contextual learning and memory.
    Jeremy D Arenos, R. Musty, David J. Bucci · 2006 · European Journal of Pharmacology
  19. Rapid High-Energy Microwave Fixation is Required to Determine the Anandamide (N-arachidonoylethanolamine) Concentration of Rat Brain
    Richard Paul Bazinet, Ho‐Joo Lee, Christian C. Felder, Amy C. Porter, Stanley Isaac Rapoport, Thad A. Rosenberger · 2005 · Neurochemical Research
  20. The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update
    Volatiana Rakotoarivelo, Thomas Z. Mayer, Mélissa Simard, Nicolas Flamand, Vincenzo Di Marzo · 2024 · Molecules
  21. Determination of endocannabinoids in nematodes and human brain tissue by liquid chromatography electrospray ionization tandem mass spectrometry
    Marko Lehtonen, Markus Storvik, Hanna Malinen, Petri Hyytiä, Merja Lakso, Seppo O. K. Auriola, Garry Wong, J. C. Callaway · 2011 · Journal of Chromatography B
  22. New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis
    Alessia Ligresti, Maria Grazia Cascio, Gareth Pryce, Sanjitha Kulasegram, Irina Beletskaya, Luciano De PETROCELLIS, Bijali Saha, Anu Mahadevan, Cristina Visintin, Jenny L. Wiley et al. · 2005 · British Journal of Pharmacology
  23. Expression and function of cannabinoid receptors in mouse islets
    Chen Li, James E. Bowe, Peter M. Jones · 2010 · Islets
  24. Endocannabinoids in endocrine and related tumours
    Maurizio Bifulco, Anna Maria Malfitano, Simona Pisanti, Chiara Laezza · 2008 · Endocrine Related Cancer
  25. The effects of cannabinoids on the endocrine system
    Magdalena Borowska, Agata Czarnywojtek, Nadia Sawicka‐Gutaj, Kosma Woliński, Maria Teresa Płazińska, Przemysław Łukasz Mikołajczak, Marek Ruchała · 2018 · Endokrynologia Polska
  26. Cannabimimetic fatty acid derivatives in cancer and inflammation
    Vincenzo Di Marzo, Dominique J. Melck, Luciano De PETROCELLIS, Tiziana Bisogno · 2000 · Prostaglandins & Other Lipid Mediators
  27. Involvement of cannabinoid CB2 receptor-mediated response and efficacy of cannabinoid CB2 receptor inverse agonist, JTE-907, in cutaneous inflammation in mice
    Yoshifumi Ueda, Naoki Miyagawa, Tomoko Matsui, Tetsudo Kaya, H. IWAMURA · 2005 · European Journal of Pharmacology
  28. Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis
    Fernando Berrendero, Antonio Sánchez, Ana Cabranes, Carmen Puerta, José Antonio Ramos, Antonio García‐Merino, Javier Fernández‐Ruíz · 2001 · Synapse
  29. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide
    Eva de Lago, Javier Fernández‐Ruíz, Silvia Ortega‐Gutiérrez, Alma Viso, María Luz López-Rodríguez, José Antonio Ramos · 2002 · European Journal of Pharmacology
  30. Structural and Functional Insights into Cannabinoid Receptors
    Xiaoting Li, Ling Shen, Tian Hua, Zhi‐Jie Liu · 2020 · Trends in Pharmacological Sciences
  31. Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain.
    Billy R. Martin, Jenny L. Wiley · 2004 · PubMed
  32. Endocannabinoids and Cancer
    Guillermo Velasco, Cristina Sánchez, Manuel Guzmán · 2015 · Handbook of experimental pharmacology
  33. Discovery of Boronic Acids as Novel and Potent Inhibitors of Fatty Acid Amide Hydrolase
    Anna Minkkilä, Susanna M. Saario, Heikki Käsnänen, Jukka Leppänen, Antti Poso, Tapio Nevalainen · 2008 · Journal of Medicinal Chemistry
  34. A structure–activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase
    Maria Grazia Cascio, Alberto Minassi, Alessia Ligresti, Giovanni Appendino, SUMNER H. BURSTEIN, Vincenzo Di Marzo · 2004 · Biochemical and Biophysical Research Communications
  35. Endocannabinoid transport tightly controls 2‐arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404
    Norbert Hájos, Satish Kathuria, T. P. Dinh, Daniele Piomelli, Tamás F. Freund · 2004 · European Journal of Neuroscience
  36. Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice
    Nicole P. Bowles, Matthew N. Hill, Sarah M. Bhagat, Ilia N. Karatsoreos, Cecilia J. Hillard, Bruce S. McEwen · 2011 · Neuroscience
  37. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits
    Michael Camilleri, Gururaj J. Kolar, María I. Vázquez‐Roque, Paula Carlson, Duane D. Burton, Alan R. Zinsmeister · 2013 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  38. CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
    Esther Martínez-Martínez, Asunción Martín-Ruiz, Paloma Martín · 2016 · Oncotarget
  39. The therapeutic potential of targeting the peripheral endocannabinoid/CB 1 receptor system
    Joseph Tam, Liad Hinden, Adi Drori, Shiran Udi, Shahar Azar, Saja Baraghithy · 2018 · European Journal of Internal Medicine
  40. Animal models of post-traumatic stress disorder and novel treatment targets
    Dario Aspesi, Graziano Pinna · 2019 · Behavioural Pharmacology
  41. Roles for the endocannabinoid system in ethanol-motivated behavior
    Angela N. Henderson, Josée Guindon, Daniel J. Morgan · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  42. 2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1
    George B. Stefano, Thomas V. Bilfinger, Christos M. Rialas, Dale G. Deutsch · 2000 · Pharmacological Research
  43. Endocannabinoids and the gut
    Luísa Pinto, Raffaele Capasso, Giulia Di Carlo, Angelo Antonio Izzo · 2002 · Prostaglandins Leukotrienes and Essential Fatty Acids
  44. Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families
    Mélissa Simard, Anne‐Sophie Archambault, Jean-Philippe C. Lavoie, Élizabeth Dumais, Vincenzo Di Marzo, Nicolas Flamand · 2022 · Biochemical Pharmacology
  45. Neuronal cytoskeleton and synaptic densities are altered after a chronic treatment with the cannabinoid receptor agonist WIN 55,212-2
    Patricia A. Tagliaferro, Alberto Javier Ramos, Emmanuel Shan Onaivi, Sergio Gustavo Evrard, Javier Lujilde, Alicia Brusco · 2006 · Brain Research
  46. The Endogenous Cannabinoid 2-Arachidonoylglycerol Is Intravenously Self-Administered by Squirrel Monkeys
    Zuzana Justinová, Sevil Yaşar, Godfrey H. Redhi, Steven R. Goldberg · 2011 · Journal of Neuroscience
  47. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: A critical revisitation
    Giorgio Ortar, Maria Grazia Cascio, Aniello Schiano Moriello, Mercedes Camalli, Enrico Morera, Marianna Nalli, Vincenzo Di Marzo · 2007 · European Journal of Medicinal Chemistry
  48. Lysophosphatidylinositol Causes Neurite Retraction via GPR55, G13 and RhoA in PC12 Cells
    Yutaro Obara, Sanae Ueno, Yoshimi Yanagihata, Norimichi Nakahata · 2011 · PLoS ONE
  49. Simultaneous Quantification of Anandamide and Other Endocannabinoids in Dorsal Vagal Complex of Rat Brainstem by LC–MS
    Jing Chen, Kalpana S. Paudel, Andrei V. Derbenev, Bret N. Smith, Audra L. Stinchcomb · 2008 · Chromatographia
  50. Highly Selective, Reversible Inhibitor Identified by Comparative Chemoproteomics Modulates Diacylglycerol Lipase Activity in Neurons
    Marc P. Baggelaar, Pascal J. P. Chameau, Vasudev Kantae, Jessica J. A. Hummel, Ku‐Lung Hsu, Freek J. Janssen, Tom van der Wel, Marjolein Soethoudt, Hui Deng, Hans den Dulk et al. · 2015 · Journal of the American Chemical Society
  51. The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2
    Makenzie L. Fulmer, Douglas P. Thewke · 2018 · Cardiovascular & Haematological Disorders - Drug Targets
  52. Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation
    Takayuki Sugiura, Naoki Yoshinaga, Keizo Waku · 2001 · Neuroscience Letters
  53. The endocannabinoid system: a physiological perspective on its role in psychomotor control
    Andrea Giuffrida, Daniele Piomelli · 2000 · Chemistry and Physics of Lipids
  54. Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats
    Daniele De Filippis, Alessandra D’Amico, Mariateresa Cipriano, Stefania Petrosino, Pierangelo Orlando, Vincenzo Di Marzo, Teresa Iuvone · 2009 · Pharmacological Research
  55. Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD
    Luke John Ney, Jane Akhurst, Raimondo Bruno, Patrick A.F. Laing, Allison Jane Matthews, Kim Louise Felmingham · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  56. Substituted 5,5‘-Diphenyl-2-thioxoimidazolidin-4-one as CB1 Cannabinoid Receptor Ligands: Synthesis and Pharmacological Evaluation
    Giulio G. Muccioli, Diana V. Martin, Gerhard K. E. Scriba, Wolfgang Poppitz, Jacques Henri Poupaert, Johan Wouters, Didier M. Lambert · 2005 · Journal of Medicinal Chemistry
  57. Disulfiram is an Inhibitor of Human Purified Monoacylglycerol Lipase, the Enzyme Regulating 2‐Arachidonoylglycerol Signaling
    Geoffray Labar, Cédric Bauvois, Giulio G. Muccioli, Johan Wouters, Didier M. Lambert · 2007 · ChemBioChem
  58. 2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective
    Alexandros Makriyannis · 2014 · Journal of Medicinal Chemistry
  59. Fatty Acid Amide Hydrolase Inhibitors from Virtual Screening of the Endocannabinoid System
    Susanna M. Saario, Antti Poso, Risto Olavi Juvonen, Tomi Järvinen, Outi M. H. Salo‐Ahen · 2006 · Journal of Medicinal Chemistry
  60. Oleic acid content of a meal promotes oleoylethanolamide response and reduces subsequent energy intake in humans
    Ilario Mennella, Maria Flavia Savarese, Rosalia Ferracane, Raffaele Sacchi, Paola Vitaglione · 2014 · Food & Function
  61. Cannabinoids prevent lipopolysaccharide-induced neurodegeneration in the rat substantia nigra in vivo through inhibition of microglial activation and NADPH oxidase
    Eun Sook Chung, Eugene Bok, Young Cheul Chung, Hyung Hwan Baik, Byung Kwan Jin · 2012 · Brain Research
  62. HU 210: A Potent Tool for Investigations of the Cannabinoid System
    Alessandra Ottani, Daniela Giuliani · 2001 · CNS Drug Reviews
  63. Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
    Styliani Vlachou, George Panagis · 2014 · Current Pharmaceutical Design
  64. Neuronal and glial localization of the cannabinoid‐1 receptor in the superficial spinal dorsal horn of the rodent spinal cord
    Z. Hegyi, G. Kis, K. Holló, C. Ledent, M. Antal · 2009 · European Journal of Neuroscience
  65. The Endocannabinoid System
    Steven T. Boyd · 2006 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  66. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways
    Despina Kokona, Kyriaki Thermos · 2015 · Experimental Eye Research
  67. Cannabinoids, the Heart of the Matter
    Naghum Alfulaij, Franziska Meiners, Justin Michalek, Andrea Lee Small-Howard, Helen C. Turner, Alexander J. Stokes · 2018 · Journal of the American Heart Association
  68. Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
    Pierangelo Cifelli, Gabriele Ruffolo, Eleonora De Felice, Veronica Alfano, Erwin Alexander van Vliet, Eleonora Aronica, Eleonora Palma · 2020 · International Journal of Molecular Sciences
  69. The Cannabinoids: An Overview. Therapeutic Implications in Vomiting and Nausea after Cancer Chemotherapy, in Appetite Promotion, in Multiple Sclerosis and in Neuroprotection
    Raphael Mechoulam, Lumir Ondrej Hanus · 2001 · Pain Research and Management
  70. Tricyclic Pyrazoles. Part 1: Synthesis and Biological Evaluation of Novel 1,4-Dihydroindeno[1,2-c]pyrazol-based Ligands for CB1and CB2 Cannabinoid Receptors
    Jean‐Mario Mussinu, Stefania Ruiu, Antonio C Mulè, Amedeo Pau, Mauro A.M. Carai, Giovanni Loriga, Gabriele Murineddu, Gerard Aime Pinna · 2003 · Bioorganic & Medicinal Chemistry
  71. Therapeutic Potential of Endocannabinoid‐Hydrolysing Enzyme Inhibitors
    Susanna M. Saario, Jarmo T. Laitinen · 2007 · Basic & Clinical Pharmacology & Toxicology
  72. The Endocannabinoid System Protects Rat Glioma Cells Against HIV-1 Tat Protein-induced Cytotoxicity
    Giuseppe Esposito, Alessia Ligresti, Angelo Antonio Izzo, Tiziana Bisogno, Menotti Ruvo, Massimo Di Rosa, Vincenzo Di Marzo, Teresa Iuvone · 2002 · Journal of Biological Chemistry
  73. Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective
    S.M. Khaledur Rahman, Toru Uyama, Zahir Hussain, Natsuo Ueda · 2021 · Annual Review of Nutrition
  74. Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC)
    Matthijs Geert Bossong, Johan Martijn Jansma, Sagnik Bhattacharyya, Nick F. Ramsey · 2014 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  75. Control of Intracellular Calcium Signaling as a Neuroprotective Strategy
    R. Scott Duncan, Daryl L. Goad, Michael A. Grillo, Simon Kaja, Andrew J. Payne, Peter Koulen · 2010 · Molecules
  76. Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling
    Stephanie C. Gantz, Bruce P. Bean · 2017 · Neuron
  77. ABHD6: Its Place in Endocannabinoid Signaling and Beyond
    Jessica K. Cao, Joshua S. Kaplan, Nephi Stella · 2019 · Trends in Pharmacological Sciences
  78. Novel 1′,1′-Chain Substituted Hexahydrocannabinols: 9β-Hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a Highly Potent Cannabinoid Receptor 1 (CB1) Agonist
    Spyros P. Nikas, Shakiru O. Alapafuja, Ioannis P. Papanastasiou, Carol Anne Paronis, Vidyanand G. Shukla, Demetris P. Papahatjis, Anna L. Bowman, Halikhedkar Aneetha, Xiuwen Han, Alexandros Makriyannis · 2010 · Journal of Medicinal Chemistry
  79. Anandamide amidohydrolase (fatty acid amide hydrolase)
    Natsuo Ueda, Shozo Yamamoto · 2000 · Prostaglandins & Other Lipid Mediators
  80. Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system
    Katarzyna Starowicz, Barbara Przewłocka · 2012 · Philosophical Transactions of the Royal Society B Biological Sciences
  81. Quantitative LC–MS/MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitor
    Bingnan Han, Rachel Wright, Aaron M. Kirchhoff, Julia A. Chester, Bruce R. Cooper, Vincent Jo Davisson, Eric L. Barker · 2012 · Analytical Biochemistry
  82. Targeting the cannabinoid system for pain relief?
    Lih‐Chu Chiou, Sherry Shu‐Jung Hu, Yu‐Cheng Ho · 2013 · Acta anaesthesiologica Taiwanica
  83. CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus
    Frédéric Bequet, Françoise Uzabiaga, Mathieu Desbazeille, Pascal Ludwiczak, Mohamed Maftouh, Claudine Picard, B. Scatton, Gérard Le Fur · 2007 · European Journal of Neuroscience
  84. Cannabidiol's Upregulation of N -acyl Ethanolamines in the Central Nervous System Requires N -acyl Phosphatidyl Ethanolamine-Specific Phospholipase D
    Emma Leishman, Meera Manchanda, Rachel Thelen, Sally Miller, Ken Mackie, Heather B. Bradshaw · 2018 · Cannabis and Cannabinoid Research
  85. Endocannabinoid chemical biology: a tool for the development of novel therapies
    Stefania Petrosino, Alessia Ligresti, Vincenzo Di Marzo · 2009 · Current Opinion in Chemical Biology
  86. The Endocannabinoid Signaling System: A Potential Target for Next- Generation Therapeutics for Alcoholism
    Balapal S. Basavarajappa · 2007 · Mini-Reviews in Medicinal Chemistry
  87. Fatty-Acid Amide Hydrolase Is Expressed in the Mouse Uterus and Embryo during the Periimplantation Period1
    Bibhash C. Paria, X. Zhao, J. Wang, Sanjoy Das, Sudhansu K. Dey · 1999 · Biology of Reproduction
  88. High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
    Marie Fitzgibbon, David P. Finn, Michelle Roche · 2015 · The International Journal of Neuropsychopharmacology
  89. The Interplay between the Immune and the Endocannabinoid Systems in Cancer
    Mariantonia Braile, Simone Marcella, Gianni Marone, Maria Rosaria Galdiero, Gilda Varricchi, Stefania Loffredo · 2021 · Cells
  90. FMR1 and Autism, an Intriguing Connection Revisited
    William Fyke, Milen T. Velinov · 2021 · Genes
  91. Design, Synthesis, and In Vitro Evaluation of Carbamate Derivatives of 2-Benzoxazolyl- and 2-Benzothiazolyl-(3-hydroxyphenyl)-methanones as Novel Fatty Acid Amide Hydrolase Inhibitors
    Mikko J. Myllymäki, Susanna M. Saario, Antti O. Kataja, Joel A. Castillo‐Melendez, Tapio Nevalainen, Risto Olavi Juvonen, Tomi Järvinen, Ari M. P. Koskinen · 2007 · Journal of Medicinal Chemistry
  92. Phytocannabinoids and Endocannabinoids
    Zdeněk Fišar · 2009 · Current Drug Abuse Reviews
  93. The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives
    Maurizio Baldassarre, Ferdinando Antonino Giannone, Lucia Napoli, Alessandra Tovoli, Carmen Serena Ricci, Manuel Tufoni, Paolo Caraceni · 2013 · Liver International
  94. Targeting the endocannabinoid system in treating brain disorders
    Ben A. Bahr, David A. Karanian, Sagar S Makanji, Alexandros Makriyannis · 2006 · Expert Opinion on Investigational Drugs
  95. Cannabinoid receptor signaling regulates liver development and metabolism
    Leah Y. Liu, Kristen Alexa, Mauricio Cortes · 2016 · Development
  96. Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
    Klára Gyires, Zoltán Zádori · 2016 · Current Neuropharmacology
  97. The cannabinoid system and its pharmacological manipulation – a review, with emphasis upon the uptake and hydrolysis of anandamide
    Christopher John Fowler · 2006 · Fundamental and Clinical Pharmacology
  98. Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor
    Alex Carrasquer, Nstang M. Nebane, Walter M. Williams, Zhao-Hui Song · 2010 · Pharmacogenetics and Genomics
  99. Endocannabinoid metabolism by cytochrome P450 monooxygenases
    Susan E. Zelasko, William R. Arnold, Aditi Das · 2014 · Prostaglandins & Other Lipid Mediators
  100. Psychopharmacology of the endocannabinoids: far beyond anandamide
    Fabrício A. Pamplona, RN Takahashi · 2011 · Journal of Psychopharmacology